INS and obesity disorder: In a HFD‐induced model of obesity and insulin resistance, we found that treatment with the Krebs cycle intermediate succinic acid seems to decrease white adipose tissue mass, though did not impact caloric intake, body mass, physical activity, or glucose/insulin tolerance.